Joseph Talamo insider trades

Open-market stock purchases and sales by Joseph Talamo, Chief Financial Officer at Intensity Therapeutics, Inc, from SEC Form 4 filings since Jun 29, 2011.

Recent trades

DateStockTradeValue
Jul 16, 2026INTS Intensity Therapeutics, IncBought (not open market)—
Jun 30, 2026INTS Intensity Therapeutics, IncBought (not open market)$3.8K
Dec 31, 2025INTS Intensity Therapeutics, IncBought (not open market)$3.8K

Companies traded

  • INTS Intensity Therapeutics, Inc: other filings, last Jul 16, 2026
  • CLBS Caladrius Biosciences, Inc: other filings, last Jan 14, 2020
  • NBS NeoStem, Inc: other filings, last Jun 2, 2015

Get free alerts when Joseph Talamo files a new trade →